ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TKNO vs IMDX // EV/EBITDA & P/E VALUATION

Alpha Teknova Inc. (NASDAQ) VS. Insight Molecular Diagnostics Inc. (NASDAQ) • 15-METRIC TALLY: TKNO 6 — IMDX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. IMDX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TKNO IMDX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.20% 56.70% -23.50 IMDX /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% -35.00% +13.70 TKNO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -1.96% -24.38% +22.42 TKNO /fcf-yield <GO>
Operating Margin -41.90% -60.00% +18.10 TKNO /operating-margins <GO>
Net Profit Margin -42.60% -1.20% -41.40 IMDX /net-margins <GO>
Revenue Growth (YoY) 7.40% 115.60% -108.20 IMDX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.93 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 TKNO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.1 41.5 +6.56 TKNO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $499.2M $104.1M $395.1M TKNO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TKNO REV IMDX REV TKNO GROSS % IMDX GROSS % TKNO FCF IMDX FCF
FY 2025 $40.5M $4.1M 33.2% 56.7% -$9.8M -$25.4M
FY 2024 $37.7M $1.9M 19.2% 39.3% -$13.5M -$21.2M
FY 2023 $36.7M $1.5M — — -$18.8M -$23.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
IMDX // BETA —